0001226555-14-000003.txt : 20140423 0001226555-14-000003.hdr.sgml : 20140423 20140423114136 ACCESSION NUMBER: 0001226555-14-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140423 DATE AS OF CHANGE: 20140423 EFFECTIVENESS DATE: 20140423 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICONIC THERAPEUTICS INC CENTRAL INDEX KEY: 0001226555 IRS NUMBER: 161653625 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-216081 FILM NUMBER: 14778079 BUSINESS ADDRESS: STREET 1: 127 PEACHTREE ST NE STE 1551 CITY: ATLANTA STATE: 2Q ZIP: 30303 BUSINESS PHONE: 404-522-8577 MAIL ADDRESS: STREET 1: 127 PEACHTREE ST NE STE 1551 CITY: ATLANTA STATE: GA ZIP: 30303 D 1 primary_doc.xml X0707 D LIVE 0001226555 ICONIC THERAPEUTICS INC 127 PEACHTREE ST STE 1551 ATLANTA 2Q GEORGIA 30303 404-522-8577 DELAWARE None None Corporation true William Greene 127 Peachtree Street Suite 1551 Atlanta GA GEORGIA 30303 Executive Officer Director Kirk Dornbush 127 Peachtree Street Suite 1551 Atlanta 2Q GEORGIA 30303 Executive Officer Director Todd Foley 127 Peachtree Street Suite 1551 Atlanta GA GEORGIA 30303 Director Johan Kordel 127 Peachtree Street Suite 1551 Atlanta GA GEORGIA 30303 Director Bruce Robertson 127 Peachtree Street Suite 1551 Atlanta GA GEORGIA 30303 Director Jon Soderstrom 127 Peachtree Street Suite 1551 Atlanta GA GEORGIA 30303 Director Biotechnology Decline to Disclose 06b false 2014-04-14 false true true (1) Series B-1 Preferred Stock; Common Stock issuable upon conversion and (2) Series A-1 Preferred Stock; Common Stock issuable upon conversion false 0 24266880 13258905 11007975 false 40 0 0 216000 true Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. false ICONIC THERAPEUTICS INC /s/Kirk Dornbush Kirk Dornbush President 2014-04-23